Iran J Microbiol. 2021 Jun;13(3):345-351. doi: 10.18502/ijm.v13i3.6397.
Curcumin-meropenem synergy in carbapenem resistant .
Iranian journal of microbiology
Dumrul Gülen, Birol Şafak, Berna Erdal, Betül Günaydın
Affiliations
Affiliations
- Department of Medical Microbiology, Tekirda? Nam?k Kemal University, Faculty of Medicine, Tekirda?, Turkey.
PMID: 34540173
PMCID: PMC8416589 DOI: 10.18502/ijm.v13i3.6397
Abstract
BACKGROUND AND OBJECTIVES: The frequency of multiple resistant bacterial infections, including carbapenems, is increasing worldwide. As the decrease in treatment options causes difficulties in treatment, interest in new antimicrobials is increasing. One of the promising natural ingredients is curcumin. It is known to be effective in bacteria such as
MATERIALS AND METHODS: Thirty-nine
RESULTS: Synergistic effects were observed in 4 isolates producing MBL, 3 isolates producing KPC, 4 isolates producing OXA-48, and 1 isolates producing AmpC (totally 12 isolates) according to the calculated FICI. No antagonistic effects were observed in any isolates.
CONCLUSION: Curcumin was thought to be an alternative antimicrobial in combination therapies that would positively contribute to the treatment of bacterial infection. The effectiveness of this combination should be confirmed by other
Copyright © 2021 The Authors. Published by Tehran University of Medical Sciences.
Keywords: Anti-bacterial agents; Carbapenemase; Curcumin; Drug synergism; Klebsiella pneumoniae
References
- Mikrobiyol Bul. 2016 Jan;50(1):21-33 - PubMed
- Front Microbiol. 2019 Aug 20;10:1823 - PubMed
- J Microbiol Immunol Infect. 2017 Oct;50(5):653-661 - PubMed
- Clin Microbiol Infect. 2014 Sep;20(9):862-72 - PubMed
- Biochem Biophys Res Commun. 2005 Jan 14;326(2):472-4 - PubMed
- Antimicrob Agents Chemother. 2006 May;50(5):1859-60 - PubMed
- Biomed Res Int. 2014;2014:186864 - PubMed
- J Korean Med Sci. 2018 Sep 03;33(40):e255 - PubMed
- Lett Appl Microbiol. 2020 Jan;70(1):42-47 - PubMed
- J Antimicrob Chemother. 2009 Feb;63(2):337-9 - PubMed
- Phytomedicine. 2013 Jun 15;20(8-9):714-8 - PubMed
- Emerg Infect Dis. 2011 Oct;17(10):1791-8 - PubMed
- Toxicol Ind Health. 2016 Feb;32(2):246-50 - PubMed
- J Antimicrob Chemother. 2013 Jan;68(1):139-52 - PubMed
- Nutrients. 2021 Apr 30;13(5): - PubMed
- Euro Surveill. 2015;20(45): - PubMed
- Antibiotics (Basel). 2019 Aug 19;8(3): - PubMed
- Mem Inst Oswaldo Cruz. 2001 Jul;96(5):723-8 - PubMed
- J Clin Microbiol. 2014 Dec;52(12):4124-8 - PubMed
- Phytomedicine. 2008 Aug;15(8):639-52 - PubMed
- Curr Infect Dis Rep. 2018 Jun 29;20(9):29 - PubMed
- Biochem J. 2008 Feb 15;410(1):147-55 - PubMed
- J Chemother. 2015 Oct;27(5):277-82 - PubMed
- Front Cell Infect Microbiol. 2019 Sep 25;9:334 - PubMed
- J Agric Food Chem. 2008 Mar 26;56(6):1955-62 - PubMed
- Phytomedicine. 2017 Dec 15;37:27-48 - PubMed
- J Clin Diagn Res. 2014 Oct;8(10):DC04-7 - PubMed
- J Chemother. 2016 Aug;28(4):297-303 - PubMed
- J Basic Clin Pharm. 2016 Jun;7(3):93-6 - PubMed
- Front Microbiol. 2015 Apr 10;6:290 - PubMed
- Biochem Pharmacol. 2008 Feb 15;75(4):787-809 - PubMed
Publication Types